US to investigate Ranbaxy drugs
Ranbaxy's worries continue, as the cloud around it gets darker. The US House Committee on Energy & Commerce says it will now investigate each and every drug that Ranbaxy has approval to market in the United States. The leaders of US house committee have also raised questions about the role of the US FDA and have sought a reply in two weeks.
